Stories from Vienna

Filter
  • 01.06.2023 – 11:00

    CROMA-PHARMA GmbH

    Croma-Pharma: Launch of topical anaesthetic Pliaglis® in Europe

    Vienna (ots/PRNewswire) - Croma-Pharma, a global player and challenger in the dynamically growing, minimally invasive aesthetics market, announces that it will launch Pliaglis®, a topical local anaesthetic for superficial dermatological procedures, in its European core markets including Germany, the United Kingdom ("UK"), and Ireland. Further markets including Brazil will follow by the end of 2023. The anaesthetic cream ...

  • 24.05.2023 – 10:53

    Incrementum AG

    In Gold We Trust Report 2023 "Showdown"

    Schaan / Vienna (ots) - On May 24, 2023, this year's - now 17th - In Gold We Trust report was presented at an international press conference broadcast live on the Internet. The authors of the report are the two fund managers Ronald-Peter Stöferle and Mark J. Valek from the Liechtenstein-based asset manager Incrementum AG. The 400+ page In Gold We Trust report is renowned worldwide and has been dubbed the "gold standard ...

  • 11.05.2023 – 11:01

    CROMA-PHARMA GmbH

    Croma-Pharma receives marketing authorisation for Letybo® in a further 12 European markets

    Vienna (ots/PRNewswire) - Croma (Croma-Pharma® GmbH) announced today that it has received marketing authorisation for Letybo®, the company's botulinum toxin product, in 12 additional European markets. These include Belgium, Cyprus, Czech Republic, Denmark, Finland, Greece, Hungary, Luxembourg, Malta, Norway, Slovakia and Sweden. Letybo® will be launched in these ...

  • 09.05.2023 – 18:38

    CROMA-PHARMA GmbH

    /C O R R E C T I O N -- Croma-Pharma/

    Vienna (ots/PRNewswire) - In the news release, Croma-Pharma reports 27% revenue growth in 2022 and targets further revenue growth in 2023 and thereafter, issued 09-May-2023 by Croma-Pharma over PR Newswire, we are advised by the company that the footnote [1] has been updated. The complete, corrected release follows: Croma-Pharma reports 27% revenue growth in 2022 and targets further revenue growth in 2023 and thereafter - ...